Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy.

MLA

Liu, Xiaodi, et al. “Nanoparticles (NPs)-Mediated Siglec15 Silencing and Macrophage Repolarization for Enhanced Cancer Immunotherapy.” Acta Pharmaceutica Sinica B, vol. 13, no. 12, Dec. 2023, pp. 5048–59. EBSCOhost, https://doi.org/10.1016/j.apsb.2023.07.012.

APA

Liu, X., Zhang, Q., Liang, Y., Xiong, S., Cai, Y., Cao, J., Xu, Y., Xu, X., Wu, Y., Lu, Q., Xu, X., & Luo, B. (2023). Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy. Acta Pharmaceutica Sinica B, 13(12), 5048–5059. https://doi.org/10.1016/j.apsb.2023.07.012

Chicago

Liu, Xiaodi, Qi Zhang, Yixia Liang, Shiyu Xiong, Yan Cai, Jincheng Cao, Yanni Xu, et al. 2023. “Nanoparticles (NPs)-Mediated Siglec15 Silencing and Macrophage Repolarization for Enhanced Cancer Immunotherapy.” Acta Pharmaceutica Sinica B 13 (12): 5048–59. doi:10.1016/j.apsb.2023.07.012.